Aims and scope

CVIR Oncology is the first journal dedicated to advancing the field of interventional oncology (IO) and related fields in cancer care and patient management. It serves as a global platform connecting the international and multidisciplinary community of IO specialists and other healthcare professionals involved in cancer care. By addressing clinical, technological, procedural innovations and standards, and translational research, CVIR Oncology supports the evolving daily clinical practices of interventional radiologists, and all other medical practitioners dedicated to cancer care.

As an open-access journal, CVIR Oncology ensures the broad dissemination of rigorously open-peer reviewed research. The journal welcomes a diverse range of article types, including original research, review articles, study protocols, short communications, editorials, letters, commentaries, new technologies and case reports. Publications focus on the latest developments in cancer therapy and treatment, emerging techniques and technologies, and ground-breaking advancements in IO.

CVIR Oncology is an official journal of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). As part of the CIRSE family of journals, it embodies the society’s dedication to promoting excellence in research and clinical practice, fostering innovation, and advancing patient care within the global IO community.

Prof. Dr. Thomas Helmberger is a leading expert in interventional oncology, oncologic imaging, and minimally invasive therapies. He earned his medical degree from the University of the Saarland and Friedrich-Alexander-University Erlangen-Nürnberg in 1985, followed by residencies in Internal Medicine (1985–1988) and Diagnostic Radiology (1988–1993), obtaining board certification in 1993.

After a research fellowship in Abdominal Imaging at the University of Florida, Gainesville (1994–1995), he served at Ludwig-Maximilians-University (LMU) Munich as Clinical Assistant Professor and Attending (1995–2000), later becoming Associate Professor and Vice Chairman (2001–2004). He was then appointed Professor of Radiology and Chairman at the University Hospitals of Schleswig-Holstein, Lübeck (2004–2007). Since 2007, he has been Director of Radiology, Neuroradiology, and Minimally Invasive Therapy at Munich Klinik Bogenhausen, an Academic Teaching Hospital of the Technical University of Munich (TUM), where he is also an Extraordinary Professor. Additionally, he serves as Vice Chairman of the Interdisciplinary Tumor Center at Munich Klinik Bogenhausen.

His research focuses on oncologic imaging and interventional therapies, including tumor ablation (RFA, MWA, radioembolization, DEB-TACE, HAI), vascular interventions, and advanced imaging strategies for abdominal tumors.

A key figure in interventional radiology, he was Founding President of the German Society of Interventional Radiology (DeGIR, 2008) and has held leadership roles within CIRSE, ESGAR, and ECR, including Congress Chair positions at CIRSE, IROS, and ECIO. He is a Distinguished Fellow of CIRSE, recipient of the Eberhard Zeitler Medal honorary member of the Turkish radiological Society and of DeGIR. He has contributed to European guidelines on oncologic imaging and interventions, and was serving as Councillor for the Accreditation Council of Oncology Europe (ACOE/UEMS), as member of the European Commission Initiative on Colorectal Cancer (ECICC), and as Councillor of  the National Cancer Institute of the Netherlands/AVL.

A highly regarded editor and reviewer, he has contributed to journals such as Radiology, European Radiology, Hepatology, Investigative Radiology, JVIR, CVIR, and Interventional Oncology. He was Co-Editor of multiple journals and in 2024 was appointed Editor-in-Chief of CVIR Oncology.

Prof. Helmberger has authored over 240 peer-reviewed papers, 25 book chapters, and delivered more than 1,000 presentations, with an h-index of 49.